NEED INFO ON ORAL THERAPY?

For more information on oral therapy and Oracea,^® visit the Oracea^® website.

FIND A DERMATOLOGIST
(Enter the first 3 digits of your zip code)

Important Safety Information

MetroGel^® 1% is indicated for the topical treatment of the inflammatory lesions of rosacea. The following adverse experiences have been reported with the topical use of metronidazole: burning, skin irritation, dryness, transient redness, metallic taste, tingling or numbness of extremities and nausea. MetroGel^® 1% gel is contraindicated in individuals with a history of hypersensitivity to metronidazole or any other ingredients in this formulation. For more information about MetroGel^®, see Full Prescribing Information.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

© 2010 Galderma Laboratories, L.P. United States, All Rights Reserved. All trademarks are the property of their respective owners. This site intended for U.S. audiences only. Information in this website is not intended as medical advice. Talk to your doctor about medical concerns.

IMPORTANT SAFETY INFORMATION

MetroGel^® 1% is indicated for the topical treatment of the inflammatory lesions of rosacea. The following adverse experiences have been reported with the topical use of metronidazole: burning, skin irritation, dryness, transient redness, metallic taste, tingling or numbness of extremities and nausea. MetroGel^® 1% gel is contraindicated in individuals with a history of hypersensitivity to metronidazole or any other ingredients in this formulation. For more information about MetroGel^®, see Full Prescribing Information.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Friend's Name:
Friend's Email
Message:

NEED INFO ON ORAL THERAPY?

Help Friends Take Control

Important Safety Information